NRC-VACC-101 vaccine

N/A

Report date: 2023/01/02 21:18:54

Base Information

Drug NameNRC-VACC-101 vaccine
Drug Alias NameCovi VaxEgyptian Inactivated SARS-CoV-2 VaccineNRC Inactivated SARS-CoV-2 VaccineNRC-VACC-101
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Drug-Related Side Effects and Adverse Reactions
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryEgypt
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesStiftung Fürstlicher Kommerzienrat Guido Feger
China Registration ClassN/A

Develop Information

Active CompaniesNational Research Centre
Inactive CompaniesStiftung Fürstlicher Kommerzienrat Guido Feger
Active IndicationsCoronavirus Disease 2019 (COVID-19)Drug-Related Side Effects and Adverse Reactions
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A